Navin Shah, MD

Drs. Navin C. Shah and Vladimir Ioffe share their insight on the Urology Times September 2020 Cover Story, “PSA Screening in Prostate Cancer—The Controversy Continues.”

"Although we commend the USPSTF for upgrading the recommendation for PSA- and digital rectal exam-based prostate cancer screening from a “D” to a “C” grade (JAMA 2018; 319:1901–13), we believe that not enough emphasis is placed on screening high-risk groups for prostate cancer," write Navin Shah, MD, and Vladimir Ioffe, MD.

“We strongly believe that PSA-based prostate cancer screening should be made available, especially to men 70 years and older to decrease the morbidity and mortality of prostate cancer,” write Navin Shah, MD, and Vladimir Ioffe, MD.